Provided by Tiger Trade Technology Pte. Ltd.

Oppenheimer

85.63
-0.2200-0.26%
Volume:30.71K
Turnover:2.64M
Market Cap:906.56M
PE:6.57
High:87.38
Open:86.21
Low:85.15
Close:85.85
52wk High:94.10
52wk Low:49.26
Shares:10.59M
Float Shares:5.93M
Volume Ratio:1.13
T/O Rate:0.52%
Dividend:0.72
Dividend Rate:0.84%
EPS(TTM):13.04
EPS(LYR):13.04
ROE:16.71%
ROA:2.36%
PB:0.99
PE(LYR):6.57

Loading ...

EquipmentShare Can Sustain Elevated Growth Profile, Oppenheimer Says

MT Newswires Live
·
Yesterday

Adial Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
Yesterday

Oppenheimer Adjusts DraftKings PT to $35 From $50, Maintains Outperform Rating

MT Newswires Live
·
Yesterday

Oppenheimer Adjusts Sixth Street Specialty Lending PT to $23 From $24, Maintains Outperform Rating

MT Newswires Live
·
Yesterday

DraftKings Is Maintained at Outperform by Oppenheimer

Dow Jones
·
Yesterday

DraftKings price target lowered to $35 from $50 at Oppenheimer

TIPRANKS
·
Yesterday

Aprea Therapeutics to Present at Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
Yesterday

EquipmentShare initiated with an Outperform at Oppenheimer

TIPRANKS
·
Yesterday

Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
Yesterday

Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

GlobeNewswire
·
Yesterday

Oppenheimer Remains a Buy on Porch Group (PRCH)

TIPRANKS
·
Feb 16

Electrovaya (ELVA) Gets a Buy from Oppenheimer

TIPRANKS
·
Feb 14

International Flavors & Fragrances Poised for Volume-Driven Recovery, Oppenheimer Says

MT Newswires Live
·
Feb 14

TE Connectivity Poised to Gain From AI, Automotive Growth, Oppenheimer Says

MT Newswires Live
·
Feb 14

Vertex Pharmaceuticals' Therapies for Kidney Diseases Could Diversify Long-Term Revenue Streams, Oppenheimer Says

MT Newswires Live
·
Feb 14

Oppenheimer Adjusts SharkNinja PT to $145 From $140, Maintains Outperform Rating

MT Newswires Live
·
Feb 13

Oppenheimer Adjusts TE Connectivity PT to $285 From $270, Maintains Outperform Rating

MT Newswires Live
·
Feb 13

Oppenheimer Adjusts BridgeBio Pharma Price Target to $83 From $81, Maintains Outperform Rating

MT Newswires Live
·
Feb 13

Oppenheimer Keeps Their Buy Rating on Waste Connections (WCN)

TIPRANKS
·
Feb 13

Oppenheimer Reaffirms Their Buy Rating on Toast Inc (TOST)

TIPRANKS
·
Feb 13